Fmoc-HoArg-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-HoArg-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-003721
CAS number
776277-76-0
Molecular Formula
C22H26N4O4
Molecular Weight
410.47
Fmoc-HoArg-OH
IUPAC Name
(2S)-6-(diaminomethylideneamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
Synonyms
Fmoc-L-Homoarg-OH; Na-Fmoc-(S)-2-amino-6-guanidinohexanoic acid; Fmoc-L-homoarginine; (2S)-6-(diaminomethylideneamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
Appearance
White powder
Purity
≥ 99% (HPLC)
Density
1.350±0.100 g/cm3
Storage
Store at 2-8 °C
InChI
InChI=1S/C22H26N4O4/c23-21(24)25-12-6-5-11-19(20(27)28)26-22(29)30-13-18-16-9-3-1-7-14(16)15-8-2-4-10-17(15)18/h1-4,7-10,18-19H,5-6,11-13H2,(H,26,29)(H,27,28)(H4,23,24,25)/t19-/m0/s1
InChI Key
QRELIJBJYZHTQU-IBGZPJMESA-N
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CCCCN=C(N)N)C(=O)O

Fmoc-HoArg-OH is a derivative of arginine used in peptide synthesis and biochemical research. Here are some key applications of Fmoc-HoArg-OH:

Peptide Synthesis: Fmoc-HoArg-OH is commonly employed as a building block in the solid-phase synthesis of peptides. The Fmoc (9-fluorenylmethyloxycarbonyl) group serves as a protecting group for the amino group of arginine during peptide assembly. This allows researchers to construct peptides with precision, facilitating the study of protein interactions and functions.

Bioconjugation: Fmoc-HoArg-OH can be used in the preparation of peptide conjugates for various applications. By incorporating this derivative into peptides, it is possible to attach other molecules, such as fluorescent labels or drugs, to the peptide chain. This capability is valuable in the development of diagnostic tools and targeted therapies.

Enzyme Substrate Studies: Fmoc-HoArg-OH serves as a useful substrate in enzyme assays to study the specificity and activity of proteases. The arginine residue is often recognized by proteolytic enzymes, providing a means to evaluate enzyme kinetics and inhibitor efficacy. This application is important for both basic biochemical research and the development of therapeutic protease inhibitors.

Functional Peptide Design: Researchers use Fmoc-HoArg-OH in the design of bioactive peptides with specific functions, such as antimicrobial or cell-penetrating properties. By incorporating this arginine derivative, peptides can be tailored to enhance cellular uptake or interaction with biological membranes. This approach aids in the creation of novel therapeutic agents and delivery systems.

1. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components
Dieter Seebach, Albert K Beck, Daniel J Bierbaum Chem Biodivers. 2004 Aug;1(8):1111-239. doi: 10.1002/cbdv.200490087.
The origins of our nearly ten-year research program of chemical and biological investigations into peptides based on homologated proteinogenic amino acids are described. The road from the biopolymer poly[ethyl (R)-3-hydroxybutanoate] to the beta-peptides was primarily a step from organic synthesis methodology (the preparation of enantiomerically pure compounds (EPCs)) to supramolecular chemistry (higher-order structures maintained through non-covalent interactions). The performing of biochemical and biological tests on the beta- and gamma-peptides, which differ from natural peptides/proteins by a single or two additional CH(2) groups per amino acid, then led into bioorganic chemistry and medicinal chemistry.
2. Interaction of alpha-and beta-oligoarginine-acids and amides with anionic lipid vesicles: a mechanistic and thermodynamic study
Thomas Hitz, Rico Iten, James Gardiner, Kenji Namoto, Peter Walde, Dieter Seebach Biochemistry. 2006 May 9;45(18):5817-29. doi: 10.1021/bi060285d.
The interaction of alpha- and beta-oligoarginine amides and acids and of alpha-polyarginine with anionic lipid vesicles was studied. The beta-oligoarginines used were beta3-homologues of the alpha-oligoarginines. Lipid bilayers were composed of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]) containing 5 mol % pyrene-PG (1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-[phospho-rac-1-glycerol]). Kinetic analysis of the binding process onto large unilamellar POPC/POPG (3:7, molar ratio) vesicles (100 nm diameter) shows biphasic time courses for all tested peptides. The first binding step is fast and takes place within approximately 10 s with no disruption of the membrane as indicated by corresponding calcein release measurements. The second binding phase is slow and occurs within the next 30-300 s with substantial membrane disruption. In this context, beta-hexa- and octaarginine amides possess higher second half-times than the beta-hexa- and octaarginine acids of the same chain length. Furthermore beta-octaarginine amide induces a calcein release approximately twice as large as that of the beta-octaarginine acid. Thermodynamic analysis of the binding process, using the complex formation model that assumes that each peptide binds independently to n POPG lipids, reveals apparent binding constants (K(app1)) of approximately 5 x 10(6)-10(8) M(-1) and n-values from 3.7 for beta-hexaarginine acid up to 24.8 for alpha-polyarginine. Although the K(app1)-values are similar, the number of binding sites clearly depends on the chemical nature of the oligoarginine: beta-oligoarginine amides and alpha-oligoarginine acids interact with more lipids than beta-oligoarginine acids of the same length. Calculation of the electrostatic contribution to the total free energy of binding reveals that for all oligoarginines only 25-30% has electrostatic origin. The remaining approximately 70-75% is nonelectrostatic, corresponding to hydrogen bonding and/or hydrophobic interactions. From the obtained data, a mechanism is suggested by which oligoarginines interact with anionic vesicles: (1) initial electrostatic interaction that is fast, nonspecific, and relatively weak; (2) nonelectrostatic interaction that is rate-limiting, stronger, and induces bilayer rigidification as well as release of aqueous contents from the vesicles.
3. On the mechanism of eukaryotic cell penetration by α- and β-oligoarginines--targeting infected erythrocytes
Faustin Kamena, Bopanna Monnanda, Danielle Makou, Stefania Capone, Krystyna Patora-Komisarska, Dieter Seebach Chem Biodivers. 2011 Jan;8(1):1-12. doi: 10.1002/cbdv.201000318.
Fluorescein-labeled α- and β-octaarginine amides were synthesized. The route, by which these oligoarginine (OA) derivatives enter cells (hepatocytes, fibroblasts, macrophages), was investigated by confocal fluorescence microscopy. Comparisons (by co-localization experiments) with compounds of known penetration modes revealed that the β-octaarginine amide also uses multiple pathways to enter cells. There was no difference between the α- and the β-OAs. Like other cell-penetrating peptides (CPPs), the β-octaarginine eventually winds up in the nucleoli of the cell nuclei (cf. Chem. Biodiversity, 2004, 1, 65). Surprisingly, there was no entry of α- or β-OA into intact and healthy human erythrocytes (which do not possess a nucleus). Blood cells infected by Plasmodium falciparum (malaria parasite) were, however, entered readily, and the OAs went all the way through a couple of membranes into the parasite. The potential of these results for delivering specific antimalarial drugs directly into the parasite is discussed.
Online Inquiry
Inquiry Basket